XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
Provided By GlobeNewswire
Last update: Nov 12, 2025
Business development: Secures royalty economic interests in two early stage partnered assets through XOMA Royalty’s announced expected acquisition of LAVA Therapeutics.
Read more at globenewswire.comNASDAQ:XOMA (11/20/2025, 8:00:02 PM)
31.83
-1.32 (-3.98%)
XOMA ROYALTY CORP - XOMA 8 5/8 PERP
NASDAQ:XOMAP (11/20/2025, 8:00:02 PM)
26.42
-0.16 (-0.6%)
XOMA ROYALTY CORP - XOMA 8 3/8 PERP
NASDAQ:XOMAO (11/20/2025, 8:00:02 PM)
25.35
-0.12 (-0.47%)
Find more stocks in the Stock Screener
